ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
FRA:EUZ - Deutsche Boerse Ag - DE0005659700 - Common Stock - Currency: EUR
EUZ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 53 industry peers in the Health Care Equipment & Supplies industry. EUZ has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EUZ is growing strongly while it is still valued neutral. This is a good combination! These ratings would make EUZ suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year EUZ was profitable.
In the past year EUZ had a positive cash flow from operations.
EUZ had positive earnings in each of the past 5 years.
Each year in the past 5 years EUZ had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.11%, EUZ is in the better half of the industry, outperforming 79.25% of the companies in the same industry.
EUZ's Return On Equity of 11.83% is amongst the best of the industry. EUZ outperforms 83.02% of its industry peers.
EUZ has a better Return On Invested Capital (11.18%) than 90.57% of its industry peers.
EUZ had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 8.25%.
The last Return On Invested Capital (11.18%) for EUZ is above the 3 year average (8.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.11% | ||
| ROE | 11.83% | ||
| ROIC | 11.18% |
ROA(3y)7.7%
ROA(5y)7.7%
ROE(3y)14.69%
ROE(5y)14.93%
ROIC(3y)8.25%
ROIC(5y)8.45%
1.3 Margins
EUZ has a better Profit Margin (10.58%) than 75.47% of its industry peers.
EUZ's Profit Margin has improved in the last couple of years.
EUZ has a Operating Margin of 21.70%. This is amongst the best in the industry. EUZ outperforms 90.57% of its industry peers.
In the last couple of years the Operating Margin of EUZ has grown nicely.
The Gross Margin of EUZ (48.01%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of EUZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.7% | ||
| PM (TTM) | 10.58% | ||
| GM | 48.01% |
OM growth 3Y3.25%
OM growth 5Y8.66%
PM growth 3Y-4.02%
PM growth 5Y2.25%
GM growth 3Y-1.27%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EUZ is still creating some value.
The number of shares outstanding for EUZ remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EUZ has more shares outstanding
EUZ has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.10 indicates that EUZ is not in any danger for bankruptcy at the moment.
EUZ has a better Altman-Z score (5.10) than 88.68% of its industry peers.
The Debt to FCF ratio of EUZ is 1.53, which is an excellent value as it means it would take EUZ, only 1.53 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.53, EUZ belongs to the top of the industry, outperforming 90.57% of the companies in the same industry.
EUZ has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, EUZ is doing good in the industry, outperforming 75.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 1.53 | ||
| Altman-Z | 5.1 |
ROIC/WACC1.56
WACC7.16%
2.3 Liquidity
A Current Ratio of 2.77 indicates that EUZ has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.77, EUZ is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
EUZ has a Quick Ratio of 2.32. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.32, EUZ belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.77 | ||
| Quick Ratio | 2.32 |
3. Growth
3.1 Past
EUZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.52%, which is quite good.
EUZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.06% yearly.
The Revenue has grown by 14.70% in the past year. This is quite good.
The Revenue has been growing slightly by 7.84% on average over the past years.
EPS 1Y (TTM)9.52%
EPS 3Y6.9%
EPS 5Y10.06%
EPS Q2Q%-44.42%
Revenue 1Y (TTM)14.7%
Revenue growth 3Y11.79%
Revenue growth 5Y7.84%
Sales Q2Q%6.38%
3.2 Future
Based on estimates for the next years, EUZ will show a very strong growth in Earnings Per Share. The EPS will grow by 29.10% on average per year.
The Revenue is expected to grow by 13.26% on average over the next years. This is quite good.
EPS Next Y55.27%
EPS Next 2Y39.32%
EPS Next 3Y29.1%
EPS Next 5YN/A
Revenue Next Year21.88%
Revenue Next 2Y15.23%
Revenue Next 3Y13.26%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 42.97, which means the current valuation is very expensive for EUZ.
The rest of the industry has a similar Price/Earnings ratio as EUZ.
EUZ is valuated expensively when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.53, which means the current valuation is very expensive for EUZ.
The rest of the industry has a similar Price/Forward Earnings ratio as EUZ.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, EUZ is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.97 | ||
| Fwd PE | 25.53 |
4.2 Price Multiples
EUZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EUZ is cheaper than 73.58% of the companies in the same industry.
EUZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EUZ is cheaper than 64.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.02 | ||
| EV/EBITDA | 16.03 |
4.3 Compensation for Growth
EUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EUZ may justify a higher PE ratio.
A more expensive valuation may be justified as EUZ's earnings are expected to grow with 29.10% in the coming years.
PEG (NY)0.78
PEG (5Y)4.27
EPS Next 2Y39.32%
EPS Next 3Y29.1%
5. Dividend
5.1 Amount
With a yearly dividend of 0.83%, EUZ is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.47, EUZ pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.83, EUZ pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
5.2 History
On average, the dividend of EUZ grows each year by 20.17%, which is quite nice.
Dividend Growth(5Y)20.17%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EUZ pays out 3.55% of its income as dividend. This is a sustainable payout ratio.
The dividend of EUZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.55%
EPS Next 2Y39.32%
EPS Next 3Y29.1%
FRA:EUZ (5/9/2025, 7:00:00 PM)
59.3
+0.7 (+1.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners23.35%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.26B
Analysts83.33
Price Target64.41 (8.62%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
Yearly Dividend0.5
Dividend Growth(5Y)20.17%
DP3.55%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.97 | ||
| Fwd PE | 25.53 | ||
| P/S | 4.52 | ||
| P/FCF | 37.02 | ||
| P/OCF | 23.77 | ||
| P/B | 5.05 | ||
| P/tB | 6.41 | ||
| EV/EBITDA | 16.03 |
EPS(TTM)1.38
EY2.33%
EPS(NY)2.32
Fwd EY3.92%
FCF(TTM)1.6
FCFY2.7%
OCF(TTM)2.49
OCFY4.21%
SpS13.12
BVpS11.74
TBVpS9.25
PEG (NY)0.78
PEG (5Y)4.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.11% | ||
| ROE | 11.83% | ||
| ROCE | 15.82% | ||
| ROIC | 11.18% | ||
| ROICexc | 15.03% | ||
| ROICexgc | 18.45% | ||
| OM | 21.7% | ||
| PM (TTM) | 10.58% | ||
| GM | 48.01% | ||
| FCFM | 12.21% |
ROA(3y)7.7%
ROA(5y)7.7%
ROE(3y)14.69%
ROE(5y)14.93%
ROIC(3y)8.25%
ROIC(5y)8.45%
ROICexc(3y)11.04%
ROICexc(5y)12.05%
ROICexgc(3y)15.63%
ROICexgc(5y)17.16%
ROCE(3y)11.67%
ROCE(5y)11.96%
ROICexcg growth 3Y-10.1%
ROICexcg growth 5Y-4.01%
ROICexc growth 3Y-6.74%
ROICexc growth 5Y1.56%
OM growth 3Y3.25%
OM growth 5Y8.66%
PM growth 3Y-4.02%
PM growth 5Y2.25%
GM growth 3Y-1.27%
GM growth 5Y1.38%
F-Score8
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 1.53 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 132.5% | ||
| Cap/Sales | 6.81% | ||
| Interest Coverage | 46.86 | ||
| Cash Conversion | 70.87% | ||
| Profit Quality | 115.42% | ||
| Current Ratio | 2.77 | ||
| Quick Ratio | 2.32 | ||
| Altman-Z | 5.1 |
F-Score8
WACC7.16%
ROIC/WACC1.56
Cap/Depr(3y)260.24%
Cap/Depr(5y)182.43%
Cap/Sales(3y)13.56%
Cap/Sales(5y)9.75%
Profit Quality(3y)22.91%
Profit Quality(5y)70.07%
High Growth Momentum
Growth
EPS 1Y (TTM)9.52%
EPS 3Y6.9%
EPS 5Y10.06%
EPS Q2Q%-44.42%
EPS Next Y55.27%
EPS Next 2Y39.32%
EPS Next 3Y29.1%
EPS Next 5YN/A
Revenue 1Y (TTM)14.7%
Revenue growth 3Y11.79%
Revenue growth 5Y7.84%
Sales Q2Q%6.38%
Revenue Next Year21.88%
Revenue Next 2Y15.23%
Revenue Next 3Y13.26%
Revenue Next 5YN/A
EBIT growth 1Y46.62%
EBIT growth 3Y15.43%
EBIT growth 5Y17.18%
EBIT Next Year79.6%
EBIT Next 3Y31.12%
EBIT Next 5YN/A
FCF growth 1Y481.5%
FCF growth 3Y-25.74%
FCF growth 5Y-5.42%
OCF growth 1Y83.05%
OCF growth 3Y2.56%
OCF growth 5Y12.19%